Humacyte Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -22.4% | +361.6% | -86.4% | +25.0% | +345.2% | -65.1% | -26.6% | +31.6% | +458.4% | -97.6% | -100.0% | – | – | – | – | -100.0% | – | – | – | -92.8% | -41.8% | +150.2% | -38.0% | +6.0% | -18.0% | – | |
| – | -17.7% | +24.3% | -10.2% | -88.2% | +836.8% | +5.6% | +5.6% | -87.4% | +614.4% | -86.0% | +630.7% | +15.5% | +18.9% | -93.6% | +156.9% | -47.0% | +1.8% | -0.6% | +99.4% | -45.2% | +4.7% | +2.5% | +411.5% | -81.3% | -39.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -140.5% | – | – | – | – | – | – | |
| – | -17.7% | +24.3% | -10.2% | +14.7% | -3.8% | +5.6% | +5.6% | +0.4% | -10.2% | +18.3% | -13.7% | +15.5% | +18.9% | -9.7% | +8.8% | +5.4% | +11.7% | -3.5% | -9.9% | -25.4% | +42.7% | -21.5% | -15.4% | +33.3% | -6.8% | – | |
| – | -16.4% | +26.1% | -28.8% | +95.8% | +12.6% | +0.1% | +0.9% | +4.3% | -8.8% | +19.5% | -7.4% | -8.6% | +18.3% | -2.0% | -1.1% | -11.5% | +8.1% | +27.2% | +1.7% | +9.5% | -4.0% | -2.5% | +202.7% | -65.6% | +1.2% | – | |
| – | -16.4% | +26.1% | -24.4% | +607.3% | -70.7% | +0.1% | +2.9% | +259.1% | -74.0% | +314.6% | -72.8% | -10.3% | +18.3% | +276.5% | -2.2% | +8.7% | +11.7% | +2.7% | +11.5% | -31.5% | +28.7% | -17.7% | -11.2% | +34.1% | -4.5% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -1.5% | -1.5% | +128.0% | -0.9% | +15.9% | +2.6% | +3.9% | +10.3% | -0.1% | +3.7% | +0.6% | -14.4% | +18.0% | +5.2% | +38.5% | -3.1% | +2.9% | +19.6% | -15.2% | +2.6% | +18.4% | -26.6% | +2.2% | – | |
| – | – | – | – | – | – | – | – | -146.6% | – | -168.6% | – | – | – | – | – | – | – | – | – | – | -196.2% | – | – | – | – | – | |
| – | – | – | -9.6% | -100.0% | +121,400.0% | +534.5% | -976.7% | – | – | -90.2% | -11,945.9% | – | -93.1% | -14.4% | -2,017.2% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | -146.6% | – | -168.6% | – | – | – | – | – | – | – | – | – | – | -196.2% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | -135.5% | – | -153.5% | – | -100,697.0% | – | – | – | – | – | – | – | – | -175.6% | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.